Was 2019 Really “The Year of NASH”?
Goldman Sachs coined 2019 as the “Year of NASH.” They weren’t wrong, but it wasn’t all positive . . . this year, NASH is expected to be the leading cause of liver transplants, and by 2030, prevalence of NASH is expected to increase by 63%. As we grow from the “Year of NASH” to the […]
Risk Management Strategies for Global Clinical Studies
An estimated 80% of clinical trials do not meet their patient enrollment goals1. Without enough patients to fill the trial, sponsors don’t have enough data to file for commercial approval. Study sites fail to meet enrollment goals for several reasons: competing studies mean patients are in demand, sites have limited timelines, awareness for the study […]
Developing Motivating NASH Clinical Outreach Materials
Understanding Key Challenges The first step to successful NASH trial enrollment is acknowledging the many challenges we face. We know we need significant patient volume in order to meet the high enrollment numbers required of the many trials enrolling or not-yet enrolling. Based on rate of diagnosis and historical information about the number of people […]
Without Focused Site Support, Your NASH Trial Will Fail to Enroll on Time
Challenges in achieving total enrollment for your NASH clinical trial are everywhere—low awareness of the condition, extremely complex diagnosis pathways, high screen/failure rates, and a highly competitive landscape just to name a few. Study sites will be under immense and immediate pressure to mine and screen patients from their database, and will also need to […]
Working Together for Total Trial Enrollment
When it comes to recruiting for a clinical trial, sponsors have one goal above all else: complete clinical trial enrollment. It is not enough for a recruitment partner to meet objectives in terms of scope and deadlines if these things are not producing enough qualified patients who randomize into the trial. Achieving total enrollment requires […]
Forecasting Total Study Enrollment
Enrollment forecasting through predictive modeling is important to help sponsors and CROs understand exactly how they are tracking towards each of their milestones. Forecasting helps study teams determine the most efficient ways to move forward or course-correct if something gets off track. When making enrollment projections, isolating advertising referrals from the number of patients coming […]
Clinical to Commercial: The Long- and Short-Term Benefits of a Physician Referral Network
An effective Physician Referral Network (PRN) is one of the most useful and cost-effective components of a clinical trial enrollment program. Yet many drug development companies fail to see the far-reaching benefits, often missing out on what can be an essential component of patient recruitment. The benefits of a PRN may begin during a single […]
Give Study Sites Time to Focus on What Matters Most: Patients
Easing the burden on clinical trial sites should be a priority for any Site Engagement team involved in patient recruitment. Developing procedures and establishing services with study sites in mind is an essential component of patient-centricity. The fewer burdens sites experience, the more engaged they will be. That gives them more time to spend caring […]
4 Keys to Successful Patient Transportation
Adding Lyft or Uber to your clinical trial service offering seems like an obvious choice. Both are available nearly everywhere in the US, including extensive services outside major cities. Even within major cities, which tend to tack on more taxes, these services are approximately 45% less expensive than a traditional taxi. Combined, Uber and Lyft […]
Considering Sex as a Variable in Clinical Trials
Over the last several decades, advances in biomedical and clinical research have improved the health and well-being of all people. Some of the progress has been aided by the landmark policy set forth by the National Institutes of Health (NIH) two years ago requiring investigators to consider sex as a biological variable. In fact, there […]